Benitec Biopharma Inc. (BNTC)
12.52
-0.19 (-1.49%)
At close: Mar 03, 2025, 3:59 PM
12.42
-0.80%
After-hours: Mar 03, 2025, 04:00 PM EST
Benitec Biopharma Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 216K | 75K | 73K | 59K | 97K | 11.32M | 455.45K | 450.31K | 346.51K | 829.13K | 1.02M | 545.73K |
| Cost of Revenue | 108K | 381K | 9K | 123K | 268.06K | 426.51K | 331.3K | 209.02K | 103.8K | 30.68K | 37.66K | 176.13K |
| Gross Profit | 108K | -306K | 64K | -64K | -171.06K | 10.89M | 124.15K | 241.29K | 242.7K | 798.45K | 980.1K | 369.6K |
| Operating Income | -22.49M | -19.08M | -17.85M | -13.6M | -8.28M | 2M | -8.55M | -15.92M | -24.96M | -13.33M | -14.4M | -8.16M |
| Interest Income | n/a | 49.55K | 46.35K | n/a | 62K | 119.06K | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -22.37M | -19.56M | -18.21M | -13.88M | -8.27M | 2.87M | -8.55M | -4.37M | -18.5M | -8.83M | -10.84M | -6.84M |
| Net Income | -21.75M | -19.56M | -18.56M | -13.78M | -8.3M | 2.87M | -8.55M | -4.37M | -18.5M | -8.83M | -10.84M | -6.42M |
| Selling & General & Admin | 6.99M | 6.38M | 6.65M | 6.51M | 5.57M | 6.66M | 6.41M | 6.99M | 8.96M | 6.17M | 7.67M | 4.39M |
| Research & Development | 15.61M | 12.77M | 11.27M | 7.02M | 3M | 2.17M | 5.06M | 5.32M | 9.92M | 4.78M | 5.86M | 3.43M |
| Other Expenses | -216K | -30K | -79K | 37K | -5K | 154.77K | 734.59 | -7.91M | -2.68M | -2.14M | -2.18M | -708.18K |
| Operating Expenses | 22.38M | 19.16M | 17.92M | 13.53M | 8.56M | 8.99M | 8.68M | 4.4M | 16.2M | 8.8M | 11.35M | 7.11M |
| Interest Expense | 904K | 33K | 32K | 6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 277K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 22.49M | 19.16M | 17.93M | 13.65M | 8.38M | 9.41M | 9.01M | 4.61M | 16.31M | 8.84M | 11.38M | 7.28M |
| Income Tax | -619K | 3K | 354K | -101K | 27K | -864.22K | 1.47K | 209.79K | -9M | 821.46K | -4.03M | -414.32K |
| Shares Outstanding (Basic) | 16.24M | 5.54M | 1.92M | 1.01M | 240.28K | 201.59K | 165.06K | 137.59K | 111.62K | 90.59K | 70.93K | 17.73K |
| Shares Outstanding (Diluted) | 4.06M | 5.54M | 1.92M | 1.01M | 240.28K | 201.59K | 165.06K | 137.6K | 111.62K | 90.59K | 70.93K | 17.73K |
| EPS (Basic) | -2.68 | -7.06 | -19.31 | -27.27 | -69.09 | 28.45 | -103.61 | -63.55 | -331.56 | -194.88 | -305.54 | -724.71 |
| EPS (Diluted) | -2.68 | -7.06 | -19.31 | -27.27 | -69.09 | 28.45 | -103.61 | -63.55 | -331.56 | -194.88 | -305.54 | -724.71 |
| EBITDA | -22.49M | -18.7M | -17.85M | -13.6M | -7.91M | 2.74M | -8.59M | -4.19M | -13.42M | -7.93M | -9.9M | -6.64M |
| Depreciation & Amortization | n/a | 381K | 392K | 424K | 374K | 154.77K | 142.51K | 166.75K | 11.54M | 74.4K | 4.5M | 1.52M |